4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-134631
Options or other derivatives
- President and CEO acquired 2,512,828 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2026-03-27 | Grant or award · Stock Option (right to buy) | +1,880,510 | 1,880,510 | D: show line 1 in the form | ||
| Brady Todd C President and CEO | 2026-03-27 | Grant or award · Bonus Units | +632,318 | 632,318 | D: show line 2 in the form |
Loading xslF345X06/ownership.xml…